P155 Adherence to quality indicators among patients with inflammatory bowel disease: an international comparative analysis
A. Weizman*1, S. Coenen2, N. Afzal1, G. Nguyen1, G. Van Assche2
1Mount Sinai Hospital, Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, Canada, 2Division of Gastroenterology and Hepatology, University of Leuven, Leuven, Belgium
Deficiencies in quality of care have been identified in a variety of inflammatory bowel disease (IBD) care domains, such as appropriate use of steroid sparing agents and preventative health maintenance measures. Many of these differences are due to practice variations among providers. The aim of this study was to assess variations in adherence to IBD-specific quality indicators across two tertiary referral centres.
A retrospective chart review measuring inpatient and outpatient quality indicators was conducted at Mount Sinai Hospital, Toronto, Canada (MSH) and the University of Leuven, Leuven, Belgium (UZL). The data were summarised using descriptive statistics and differences in quality indicators were assessed using the Fischer’s exact test. A
Among 450 outpatients (MSH = 225, UZL = 225), 269 (59.8%) had CD, 169 (37.7%) had UC, and 12 (2.7%) had IBD-U. All patients at UZL had undergone a post-operative colonoscopy to assess for recurrent disease within 12 months of surgery, when compared with 78% of patients at MSH (
There were important differences in adherence to many of the quality indicators across two IBD referral centres. These differences underscore the notion that practice variations exist in managing complex IBD patients, even at IBD centres of excellence. Moreover, the regional variations noted underscore the importance of adapting quality improvement initiatives to the local context.